Excellent tolerance to cilnidipine in hypertensives with amlodipine - induced edema
Authors:
Open Access
- 1 January 2013
- journal article
- research article
- Published by Medknow in North American Journal of Medical Sciences
- Vol. 5 (1) , 47-50
Abstract
Background: Ankle edema is a common adverse effect of amlodipine, an L-type calcium channel blocker (CCB). Cilnidipine is a newer L/N-type CCB, approved for treatment of essential hypertension. Aim: This study was designed to determine whether cilnidipine can produce resolution of amlodipine-induced edema while maintaining adequate control of hypertension. Materials and Methods: A prospective study was performed on 27 patients with essential hypertension with amlodipine-induced edema. Concomitant nephropathy, cardiac failure, hepatic cirrhosis, or other causes of edema, and secondary hypertension were excluded by appropriate tests. Amlodipine therapy was substituted in all the cases with an efficacy-equivalent dose of cilnidipine. Clinical assessment of ankle edema and measurement of bilateral ankle circumference, body weight, blood pressure, and pulse rate were performed at onset of the study and after 4 weeks of cilnidipine therapy. Results: At completion of the study, edema had resolved in all the patients. There was a significant decrease in bilateral ankle circumference and body weight ( P < 0.001). There was no significant change in mean arterial blood pressure and pulse rate. Conclusions: Therapy with cilnidipine resulted in complete resolution of amlodipine-induced edema in all the cases without significant worsening of hypertension or tachycardia. Cilnidipine is an acceptable alternative antihypertensive for patients with amlodipine-induced edema.Keywords
This publication has 25 references indexed in Scilit:
- Anasarca Edema with Amlodipine TreatmentAnnals of Pharmacotherapy, 2005
- Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensivesAmerican Journal of Hypertension, 2002
- Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad.2002
- ManidipineDrugs, 2001
- Safety Profile of LacidipineDrugs, 1999
- Efficacy and Tolerability of Nisoldipine Coat-Core Formulation in the Treatment of Essential Hypertension The South African Multicenter ANCHOR StudyAmerican Journal of Hypertension, 1997
- Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.1996
- Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoringEuropean Journal of Clinical Pharmacology, 1995
- Sustained blood pressure control with controlled-release isradipineAmerican Journal of Hypertension, 1995
- The safety of amlodipineAmerican Heart Journal, 1989